Gary,
I am not sure if Mitch was asked about the 60% tumor reduction, in the break out session after his presentation at the Stock Holders Meeting.
What I can add to what you have said is this. The information about the 60% was never volunteered. The answer came about because in the Break out session, Dr. Lambert was asked to talk about those results, and asked why the patient relapsed. He said that the patient relapsed because they had to stop treating the patient because of severe Diarhea brought on by his/her condition, and had nothing to do with the treatment/dosing. It took awhile to address this problem, and since no treatments were being given, there was a relapse.
What we know about this patient, only came about because Dr. Lambert was asked, and he was kind enough to answer. I am not sure that we would have ever found out if we did not have that Stock Holders Meeting and break out session.
Is there is anyone out there that can say that they talked to someone from the company that has given a similar answer to that question, they have not been mentioned, to my knowledge.
Ed |
